Xcout Intel
Albatroz Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Albatroz Therapeutics among drug discovery companies — ranked by similarity to what Albatroz Therapeutics actually does, not by market-cap band.
Subscribe to see Albatroz Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Albatroz Therapeutics
Albatroz Therapeutics is a pre-clinical stage biotechnology company based in Singapore that is developing first-in-class antibody therapeutics to protect the extracellular matrix and treat solid tumors.
Albatroz Therapeutics at a glance
Albatroz Therapeutics is a drug discovery company headquartered in Singapore. Its most recent funding round, Seed, raised $3M in April 2023. Xcout tracks 3 named people at Albatroz Therapeutics, including Christopher Tan (CFO).
Albatroz Therapeutics leadership
- Christopher TanCFO
- Frederic BardCEO & Scientific Co-Founder
- Guy HeathersCBO & Business Co-Founder
Albatroz Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Albatroz Therapeutics competitors
Ranked by semantic similarity — how close each company is to Albatroz Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Similar drug discovery company
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Similar drug discovery company
Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
Similar drug discovery company
RyboDyn is a biotechnology company that uses its proprietary RyboCypher platform, combining RNA sequencing and AI, to decode the dark proteome and identify hidden cancer targets. The company develops next-generation, antibody-based immunotherapies designed to address critical unmet needs in cancer treatment.
Similar drug discovery company
Peptomyc is a clinical-stage biotechnology company headquartered in Barcelona, Spain, specializing in the development of protein and peptide therapeutics for cancer.
Similar drug discovery company
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Similar drug discovery company
LyncBio Therapeutics is an innovative drug discovery and development company headquartered in Shanghai, China, with research facilities in Suzhou. The firm specializes in the advancement of antibody-drug conjugate (ADC) therapeutics.
Biopharma
Arch Oncology is a clinical-stage immuno-oncology company headquartered in Brisbane, California, with an additional scientific research laboratory in St. Louis, Missouri. The company develops antibody-based cancer therapies.
Similar drug discovery company
PAQ Therapeutics is a clinical-stage biotechnology company that utilizes autophagy to develop small-molecule KRAS degraders for the treatment of lethal cancers. The company's research focuses on restoring health and curing diseases that currently lack effective treatment options.
Similar drug discovery company
Mabsoft Therapeutics is a biopharmaceutical company focused on the discovery and development of innovative therapeutic solutions, including antibody-drug conjugates and immuno-stimulating antibody conjugates for solid tumors and infectious diseases. The company's pipeline features proprietary candidates such as the antibody-drug conjugate MST-168.
Similar drug discovery company
Sarcomatrix Therapeutics Corp. is a biopharmaceutical and biotechnology research company headquartered in Reno, Nevada. The company is dedicated to pioneering muscle regeneration therapies and advancing novel therapeutics to treat muscle-wasting diseases.
Similar drug discovery company
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Albatroz Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Albatroz Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →